Gulam Waris

4.4k total citations · 1 hit paper
19 papers, 2.7k citations indexed

About

Gulam Waris is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Gulam Waris has authored 19 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 10 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Gulam Waris's work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (6 papers). Gulam Waris is often cited by papers focused on Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (6 papers). Gulam Waris collaborates with scholars based in United States, India and Italy. Gulam Waris's co-authors include Haseeb Ahsan, Aleem Siddiqui, Guozhong Gong, Keith D. Tardif, Kyung-Won Huh, Lance Presser, Khursheed Alam, Akshaya Ramachandran, Binod Kumar and Shameema Sarker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Gulam Waris

19 papers receiving 2.6k citations

Hit Papers

Reactive oxygen species: role in the development of cance... 2006 2026 2012 2019 2006 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gulam Waris United States 16 1.0k 871 726 330 294 19 2.7k
Tinghong Ye China 38 1.9k 1.8× 590 0.7× 410 0.6× 468 1.4× 683 2.3× 126 4.1k
Sabine Mihm Germany 28 927 0.9× 1.2k 1.4× 1.2k 1.7× 993 3.0× 282 1.0× 71 3.6k
Yoshinori Inagaki Japan 28 1.1k 1.0× 402 0.5× 453 0.6× 238 0.7× 416 1.4× 125 2.7k
Rong‐Guang Shao China 32 1.8k 1.8× 443 0.5× 225 0.3× 208 0.6× 585 2.0× 120 2.8k
Maria Chiara Monti Italy 32 1.1k 1.1× 444 0.5× 222 0.3× 178 0.5× 702 2.4× 134 2.7k
Matthias Ocker Germany 39 2.9k 2.8× 574 0.7× 302 0.4× 342 1.0× 1.1k 3.7× 161 5.0k
Seung Hyun Oh South Korea 30 1.4k 1.3× 233 0.3× 127 0.2× 243 0.7× 402 1.4× 100 2.6k
Tae‐Wook Chung South Korea 31 2.6k 2.5× 431 0.5× 194 0.3× 757 2.3× 462 1.6× 129 4.5k
Itaru Yamamoto Japan 27 702 0.7× 217 0.2× 362 0.5× 243 0.7× 146 0.5× 110 2.2k

Countries citing papers authored by Gulam Waris

Since Specialization
Citations

This map shows the geographic impact of Gulam Waris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gulam Waris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gulam Waris more than expected).

Fields of papers citing papers by Gulam Waris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gulam Waris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gulam Waris. The network helps show where Gulam Waris may publish in the future.

Co-authorship network of co-authors of Gulam Waris

This figure shows the co-authorship network connecting the top 25 collaborators of Gulam Waris. A scholar is included among the top collaborators of Gulam Waris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gulam Waris. Gulam Waris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ramachandran, Akshaya, Binod Kumar, Gulam Waris, & David N. Everly. (2021). Deubiquitination and Activation of the NLRP3 Inflammasome by UCHL5 in HCV-Infected Cells. Microbiology Spectrum. 9(1). e0075521–e0075521. 26 indexed citations
2.
Ramachandran, Akshaya, et al.. (2020). Anti-fibrotic activity of gold and platinum complexes – Au(I) compounds as a new class of anti-fibrotic agents. Journal of Inorganic Biochemistry. 206. 111023–111023. 10 indexed citations
4.
Çevik, Özge, Dan Li, Erdene Baljinnyam, et al.. (2017). Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma. Journal of Biological Chemistry. 292(52). 21676–21689. 35 indexed citations
5.
Patil, Renukadevi, et al.. (2017). Novel 5-arylthio-5H-chromenopyridines as a new class of anti-fibrotic agents. Bioorganic & Medicinal Chemistry Letters. 27(5). 1129–1135. 18 indexed citations
6.
Grice, Kyle A., et al.. (2017). Understanding the structure and reactivity of the C–S linkage in biologically active 5-arylthio-5H-chromenopyridines. New Journal of Chemistry. 42(2). 1151–1158. 15 indexed citations
7.
Kotturi, Hari, Gulam Waris, Altaf Mohammed, et al.. (2016). (Z)-3,5,4′-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression. Cancer Research. 76(16). 4887–4896. 31 indexed citations
9.
Presser, Lance, et al.. (2011). Hepatitis C virus-induced furin and thrombospondin-1 activate TGF-β1: Role of TGF-β1 in HCV replication. Virology. 412(2). 284–296. 50 indexed citations
10.
Waris, Gulam, et al.. (2007). Binding of superoxide-modified DNA by cancer antibodies.. PubMed. 26(4). 499–504. 2 indexed citations
11.
Waris, Gulam & Haseeb Ahsan. (2006). Reactive oxygen species: role in the development of cancer and various chronic conditions.. Journal of Carcinogenesis. 5(1). 14–14. 1135 indexed citations breakdown →
12.
Tardif, Keith D., Gulam Waris, & Aleem Siddiqui. (2005). Hepatitis C virus, ER stress, and oxidative stress. Trends in Microbiology. 13(4). 159–163. 211 indexed citations
13.
Waris, Gulam & Khursheed Alam. (2004). Immunogenicity of superoxide radical modified-DNA: studies on induced antibodies and SLE anti-DNA autoantibodies. Life Sciences. 75(22). 2633–2642. 31 indexed citations
14.
Waris, Gulam, Shameema Sarker, & Aleem Siddiqui. (2004). Two-step affinity purification of the hepatitis C virus ribonucleoprotein complex. RNA. 10(2). 321–329. 30 indexed citations
15.
Waris, Gulam & Aleem Siddiqui. (2003). Regulatory mechanisms of viral hepatitis B and C. Journal of Biosciences. 28(3). 311–321. 63 indexed citations
16.
Waris, Gulam, Keith D. Tardif, & Aleem Siddiqui. (2002). Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-κB and STAT-3. Biochemical Pharmacology. 64(10). 1425–1430. 114 indexed citations
17.
Waris, Gulam & Aleem Siddiqui. (2002). Interaction between STAT-3 and HNF-3 Leads to the Activation of Liver-Specific Hepatitis B Virus Enhancer 1 Function. Journal of Virology. 76(6). 2721–2729. 65 indexed citations
18.
Waris, Gulam, Kyung-Won Huh, & Aleem Siddiqui. (2001). Mitochondrially Associated Hepatitis B Virus X Protein Constitutively Activates Transcription Factors STAT-3 and NF-κB via Oxidative Stress. Molecular and Cellular Biology. 21(22). 7721–7730. 277 indexed citations
19.
Gong, Guozhong, et al.. (2001). Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proceedings of the National Academy of Sciences. 98(17). 9599–9604. 493 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026